Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2009

01-09-2009 | Original Paper

Substantially reduced expression of PIAS1 is associated with colon cancer development

Authors: Domenico Coppola, Vevek Parikh, David Boulware, George Blanck

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2009

Login to get access

Abstract

Purpose

Protein inhibitors of activated STATs (PIAS) regulate the interferon-gamma (IFN-γ) signaling pathway, which has numerous effects on tumor development and tumor cell biology. PIAS’s also regulate STAT family members not directly involved in IFN-γ signaling. This project was designed to assess PIAS1 expression in colon cancer.

Methods

To determine whether PIAS1, one of the PIAS family members, or IFN-γ signaling pathway components could be used to stratify colon tumors, we stained tissue microarrays for PIAS1, interferon regulatory factor-1 (IRF-1) and STAT1α.

Results

PIAS1 staining of the colon cancer tissue microarrays indicated a strong correlation of normal colon cells, and adenomas, with high expression of both PIAS1 and IRF-1.

Conclusion

The PIAS1 results in particular may represent a basis for new approaches for efficiently distinguishing adenomas from colon cancer.
Literature
go back to reference Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A et al (2005) Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26:1527–1535. doi:10.1093/carcin/bgi113 PubMedCrossRef Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A et al (2005) Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26:1527–1535. doi:10.​1093/​carcin/​bgi113 PubMedCrossRef
go back to reference Eason DD, Blanck G (2001) High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway. J Immunol 166:1041–1048PubMed Eason DD, Blanck G (2001) High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway. J Immunol 166:1041–1048PubMed
go back to reference Guo W, Romano J (2007) A generalized Sidak-Holm procedure and control of generalized error rates under independence. Stat Appl Genet Mol Biol 6: (article 3) Guo W, Romano J (2007) A generalized Sidak-Holm procedure and control of generalized error rates under independence. Stat Appl Genet Mol Biol 6: (article 3)
go back to reference Klampfer L, Huang J, Swaby LA, Augenlicht L (2004) Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 279:30358–30368PubMedCrossRef Klampfer L, Huang J, Swaby LA, Augenlicht L (2004) Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem 279:30358–30368PubMedCrossRef
go back to reference Luo XM, Ross AC (2005a) Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem 280:36228–36236. doi:10.1074/jbc.M505749200 PubMedCrossRef Luo XM, Ross AC (2005a) Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem 280:36228–36236. doi:10.​1074/​jbc.​M505749200 PubMedCrossRef
go back to reference Luo XM, Ross AC (2005b) Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem 280:36228–36236. doi:10.1074/jbc.M505749200 PubMedCrossRef Luo XM, Ross AC (2005b) Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1. J Biol Chem 280:36228–36236. doi:10.​1074/​jbc.​M505749200 PubMedCrossRef
go back to reference Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A (2004) The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 279:19712–19720. doi:10.1074/jbc.M313023200 PubMedCrossRef Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A (2004) The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 279:19712–19720. doi:10.​1074/​jbc.​M313023200 PubMedCrossRef
go back to reference Stempelj M, Kedinger M, Augenlicht L, Klampfer L (2007) Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 282:9797–9804. doi:10.1074/jbc.M609426200 PubMedCrossRef Stempelj M, Kedinger M, Augenlicht L, Klampfer L (2007) Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J Biol Chem 282:9797–9804. doi:10.​1074/​jbc.​M609426200 PubMedCrossRef
go back to reference Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T (1996) Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229:21–26. doi:10.1006/bbrc.1996.1752 PubMedCrossRef Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T (1996) Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229:21–26. doi:10.​1006/​bbrc.​1996.​1752 PubMedCrossRef
go back to reference Xi H, Eason D, Ghosh D, Dovhey S, Wright K, Blanck G (1999) Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) Type IV promoter by interferon regulatory factors 1 and 2. Oncogene 18:5889–5903. doi:10.1038/sj.onc.1202969 PubMedCrossRef Xi H, Eason D, Ghosh D, Dovhey S, Wright K, Blanck G (1999) Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) Type IV promoter by interferon regulatory factors 1 and 2. Oncogene 18:5889–5903. doi:10.​1038/​sj.​onc.​1202969 PubMedCrossRef
Metadata
Title
Substantially reduced expression of PIAS1 is associated with colon cancer development
Authors
Domenico Coppola
Vevek Parikh
David Boulware
George Blanck
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0570-z

Other articles of this Issue 9/2009

Journal of Cancer Research and Clinical Oncology 9/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.